Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer von Colleoni, M, Price, K, Castiglione-Gertsch, M, Goldhirsch, A, Coates, A, Lindtner, J, Collins, J, Gelber, R.D, Thürlimann, B, Rudenstam, C.M

Volltext

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up von Castiglione-Gertsch, M., Johnsen, C., Goldhirsch, A., Gelber, R. D., Rudenstam, C. M., Collins, J., Lindtner, J., Hacking, A., Cortes-Funes, H., Forbes, J., Simpson, J., Tattersall, M.H. N., Brunner, K., Cavalli, F., Senn, H.J.

Volltext

Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis von Davis, Ben W., Gelber, Richard, Goldhirsch, Aron, Hartmann, William H., Hollaway, Linda, Russell, Ian, Rudenstam, C.M.

Volltext

The prediction of response to chemotherapy in invasive breast carcinoma by determination of histological grade von Pinder, S.E., Murray, S., Ellis, I.O., Trihia, H., Elston, C.W., Gelber, R.D., Goldhirsch, A., Lindtner, J., Cortés-Funes, H., Simoncini, E., Byrne, M.J., Golouh, R., Rudenstam, C.M., Castiglione-Gertsch, M.

Volltext

Evaluation of hepatic dearterialization in primary and secondary cancer of the liver von Almersjö, O., Bengmark, S., Rudenstam, C.M., Hafström, Lo, Nilsson, L.A.V.

Volltext